Telehealth

Remote healthcare provided by tools like video conferencing, mHealth, and vital signs monitoring.

LUX TAKE:

Clients need to know that telehealth as a technology is far more than video and text based conferencing. The companies that are going to thrive in this landscape are those that supplement their traditional synchronous and asynchronous care platforms with innovative mHealth solutions and machine learning-based diagnostic support. Big-name telehealth providers like Babylon Health leverage market ...

Lux Take last updated on September 14, 2020
Data last updated on November 26, 2020

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent telehealth developments.

News Commentaries

Telehealth provider MDLive receives $50 million investment round; will need to look to remote monitoring devices to stay competitive (September 21, 2020)

Amwell files for IPO, will need to invest in remote monitoring platform to succeed (August 28, 2020)

New Lux Content

Innovation Digest: The Lux Take on the Future of Digital Biomarkers (November 23, 2020)

BetterHelp (November 18, 2020)

New Patents

Computing...

New Investment Rounds

Computing...

Categories	Consumer Health Market, Mobile Health (mHealth)
Related companies	ResApp Health, MyDoc, Tyto Care , Hims, Nurx, IDx, Telehealth Indonesia, Eagle Telemedicine, QueerDoc, Eko, StethoMe

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978